AlphaYouMA
Insider buying
Matthew Angel bought $500K of Tempest Therapeutics, Inc. (TPST) stock
Matthew Angel, CEO and President, 10% of Tempest Therapeutics, Inc. (TPST), bought 231,482 shares of TPST stock worth $500K, per an SEC Form 4 filed Jun 23, 2026.
The shares came through a private deal, not the open market.
The trade happened on Mar 24, 2026, 91 days before it was made public.
TPST has moved -55.0% since the trade date, from $1.75 to $0.79 (Oct 6, 2026 close).
- Traded
- Mar 24, 2026
- Disclosed
- Jun 23, 2026
- Filing delay
- 91 days
- Price since
- -55.0%
- Role
- CEO and President, 10%
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.